@article{124e839db3a94a95915df8aa36d399e9,
title = "Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (Advances in Therapy, (2019), 36, 10, (2910-2926), 10.1007/s12325-019-01052-y)",
abstract = "In the Original Publication the colors of Figure 2 have been switched. The correct figures are given below.",
author = "Glassberg, {Marilyn K.} and Nathan, {Steven D.} and Lin, {Chin Yu} and Morgenthien, {Elizabeth A.} and Stauffer, {John L.} and Willis Chou and Noble, {Paul W.}",
note = "Publisher Copyright: {\textcopyright} 2019, The Author(s).",
year = "2019",
month = oct,
day = "1",
doi = "10.1007/s12325-019-01082-6",
language = "English (US)",
volume = "36",
pages = "2927--2929",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Health Communications Inc.",
number = "10",
}